Related Experiment Video
Updated: Jul 13, 2026
12:24
Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart
Published on: September 28, 2016
Acute hyperglycaemia does not alter coronary vascular function in isolated, perfused rat hearts
R E Klabunde1, K M Ryan, C E Paxson
1Department of Biomedical Sciences, Ohio University College of Osteopathic Medicine, Athens, OH 45701, USA. klabunde@ohio.edu
Diabetes, Obesity & Metabolism
|August 19, 2007
Summary
Acute hyperglycemia in rat hearts did not affect coronary vascular responses to nitric oxide (NO) or adenosine (ADO). This study found no significant changes in alpha(1)-adrenoceptor-mediated vasoconstriction to phenylephrine (PHE).
Area of Science:
- Cardiovascular Physiology
- Metabolic Research
- Pharmacology
Background:
- Hyperglycemia is a hallmark of diabetes, impacting vascular function.
- Understanding acute effects of hyperglycemia on coronary vasculature is crucial for cardiovascular health.
- Nitric oxide (NO) and adenosine (ADO) are key regulators of coronary blood flow.
Purpose of the Study:
- To investigate if acute hyperglycemia alters coronary vascular responses to NO, ADO, and phenylephrine (PHE) in non-diabetic rat hearts.
- To test the hypothesis that elevated glucose levels affect coronary vasodilation and vasoconstriction.
- To assess the impact of acute hyperglycemia on NO bioavailability.
Main Methods:
- Isolated, Langendorff-perfused, non-beating rat hearts were used.
- Hearts were perfused with Krebs-Henseleit solution under normoglycemic (100 mg/dl glucose) or hyperglycemic (500 mg/dl glucose) conditions for 60 minutes.
- Coronary vascular resistance changes were measured in response to ADO, sodium nitroprusside (SNP), PHE, and L-NAME (NO synthase inhibitor).
Main Results:
- Hyperglycemia did not alter vasodilator responses to ADO or SNP, with or without L-NAME.
- Vasoconstrictor responses to L-NAME and PHE were not changed by acute hyperglycemia compared to normoglycemia.
- These findings indicate no significant impact on NO bioavailability or alpha(1)-adrenoceptor function.
Conclusions:
- Sixty minutes of acute hyperglycemia (500 mg/dl glucose) does not significantly affect coronary vascular smooth muscle responses to NO, ADO, or PHE in isolated rat hearts.
- The unchanged vasoconstrictor response to L-NAME suggests that acute hyperglycemia does not impair NO bioavailability.
- These results contribute to understanding the immediate vascular consequences of elevated blood glucose levels.
